Skip to main content
Erschienen in: Current Osteoporosis Reports 2/2012

01.06.2012 | Skeletal Biology (D Burr, Section Editor)

Osteocyte Signaling in Bone

verfasst von: Mitchell B. Schaffler, Oran D. Kennedy

Erschienen in: Current Osteoporosis Reports | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Osteocytes, the cells residing within the bone matrix and comprising 90 % to 95 % of the all bone cells, have long been considered quiescent bystander cells compared to the osteoblasts and osteoclasts whose activities cause bone gain and loss, and whose dysfunction lead to growth defects and osteoporosis. However, recent studies show that osteocytes play a crucial, central role in regulating the dynamic nature of bone in all its diverse functions. Osteocytes are now known to be the principal sensors for mechanical loading of bone. They produce the soluble factors that regulate the onset of both bone formation and resorption. Osteocytes regulate local mineral deposition and chemistry at the bone matrix level, and they also function as endocrine cells producing factors that target distant organs such as the kidney to regulate phosphate transport. Osteocytes appear to be the major local orchestrator of many of bone’s functions.
Literatur
1.
Zurück zum Zitat Bonewald L. Osteocytes. In: Marcus R, editor. Osteoporosis, 3rd ed. Elsevier; 2008. p. 170–89. Bonewald L. Osteocytes. In: Marcus R, editor. Osteoporosis, 3rd ed. Elsevier; 2008. p. 170–89.
2.
Zurück zum Zitat Gu G, Nars M, Hentunen TA, et al. Isolated primary osteocytes express functional gap junctions in vitro. Cell Tissue Res. 2006;323(2):263–71.PubMedCrossRef Gu G, Nars M, Hentunen TA, et al. Isolated primary osteocytes express functional gap junctions in vitro. Cell Tissue Res. 2006;323(2):263–71.PubMedCrossRef
3.
Zurück zum Zitat Feng JQ, Ward LM, Liu S, et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet. 2006;38(11):1310–5.PubMedCrossRef Feng JQ, Ward LM, Liu S, et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet. 2006;38(11):1310–5.PubMedCrossRef
4.
Zurück zum Zitat He G, George A. Dentin matrix protein 1 immobilized on type I collagen fibrils facilitates apatite deposition in vitro. J Biol Chem. 2004;279(12):11649–56.PubMedCrossRef He G, George A. Dentin matrix protein 1 immobilized on type I collagen fibrils facilitates apatite deposition in vitro. J Biol Chem. 2004;279(12):11649–56.PubMedCrossRef
5.
Zurück zum Zitat Ruchon AF, Tenenhouse HS, Marcinkiewicz M, et al. Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers. J Bone Miner Res. 2000;15(8):1440–50.PubMedCrossRef Ruchon AF, Tenenhouse HS, Marcinkiewicz M, et al. Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers. J Bone Miner Res. 2000;15(8):1440–50.PubMedCrossRef
6.
Zurück zum Zitat A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat Genet. 1995;11(2):130–6. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat Genet. 1995;11(2):130–6.
7.
Zurück zum Zitat Fisher LW, Fedarko NS. Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res. 2003;44 Suppl 1:33–40.PubMed Fisher LW, Fedarko NS. Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res. 2003;44 Suppl 1:33–40.PubMed
8.
Zurück zum Zitat Rowe PS, Garrett IR, Schwarz PM, et al. Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP). Bone. 2005;36(1):33–46.PubMedCrossRef Rowe PS, Garrett IR, Schwarz PM, et al. Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP). Bone. 2005;36(1):33–46.PubMedCrossRef
9.
Zurück zum Zitat Gowen LC, Petersen DN, Mansolf AL, et al. Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem. 2003;278(3):1998–2007.PubMedCrossRef Gowen LC, Petersen DN, Mansolf AL, et al. Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem. 2003;278(3):1998–2007.PubMedCrossRef
10.
Zurück zum Zitat Liu SG, Quarles LD. How fibroblast growth factor 23 works. J Am Soc Nephrol. 2007;18(6):1637–47.PubMedCrossRef Liu SG, Quarles LD. How fibroblast growth factor 23 works. J Am Soc Nephrol. 2007;18(6):1637–47.PubMedCrossRef
11.
Zurück zum Zitat Liu S, Zhou J, Tang W, et al. Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab. 2006;291(1):E38–49.PubMedCrossRef Liu S, Zhou J, Tang W, et al. Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab. 2006;291(1):E38–49.PubMedCrossRef
12.
Zurück zum Zitat Liu S, Guo R, Simpson LG, et al. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem. 2003;278(39):37419–26.PubMedCrossRef Liu S, Guo R, Simpson LG, et al. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem. 2003;278(39):37419–26.PubMedCrossRef
13.
Zurück zum Zitat Poole KE, van Bezooijen RL, Loveridge N, et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J. 2005;19(13):1842–4.PubMed Poole KE, van Bezooijen RL, Loveridge N, et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J. 2005;19(13):1842–4.PubMed
15.
Zurück zum Zitat Balemans W, Ebeling M, Patel N, et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet. 2001;10(5):537–43.PubMedCrossRef Balemans W, Ebeling M, Patel N, et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet. 2001;10(5):537–43.PubMedCrossRef
16.
Zurück zum Zitat Li X, Ominsky MS, Niu QT, et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res. 2008;23(6):860–9.PubMedCrossRef Li X, Ominsky MS, Niu QT, et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res. 2008;23(6):860–9.PubMedCrossRef
17.
Zurück zum Zitat Bodine PV, Vernon SK, Komm BS. Establishment and hormonal regulation of a conditionally transformed preosteocytic cell line from adult human bone. Endocrinology. 1996;137(11):4592–604.PubMedCrossRef Bodine PV, Vernon SK, Komm BS. Establishment and hormonal regulation of a conditionally transformed preosteocytic cell line from adult human bone. Endocrinology. 1996;137(11):4592–604.PubMedCrossRef
18.
Zurück zum Zitat Kato Y, Boskey A, Spevak L, et al. Establishment of an osteoid preosteocyte-like cell MLO-A5 that spontaneously mineralizes in culture. J Bone Miner Res. 2001;16(9):1622–33.PubMedCrossRef Kato Y, Boskey A, Spevak L, et al. Establishment of an osteoid preosteocyte-like cell MLO-A5 that spontaneously mineralizes in culture. J Bone Miner Res. 2001;16(9):1622–33.PubMedCrossRef
19.
Zurück zum Zitat Kato Y, Windle JJ, Koop BA, et al. Establishment of an osteocyte-like cell line, MLO-Y4. J Bone Miner Res. 1997;12(12):2014–23.PubMedCrossRef Kato Y, Windle JJ, Koop BA, et al. Establishment of an osteocyte-like cell line, MLO-Y4. J Bone Miner Res. 1997;12(12):2014–23.PubMedCrossRef
20.
Zurück zum Zitat Rosser J, Bonewald LF. Studying osteocyte function using the cell lines MLO-Y4 and MLO-A5. Methods Mol Biol. 2012;816:67–81.PubMedCrossRef Rosser J, Bonewald LF. Studying osteocyte function using the cell lines MLO-Y4 and MLO-A5. Methods Mol Biol. 2012;816:67–81.PubMedCrossRef
21.
Zurück zum Zitat • Al-Dujaili SA, Lau E, Al-Dujaili H, et al. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro. J Cell Biochem. 2011;112(9):2412–23. Describes an in vitro model used to study gene expression of MLO-Y4 cells undergoing apoptosis, and the subsequent effect on osteoclastogenesis.PubMedCrossRef • Al-Dujaili SA, Lau E, Al-Dujaili H, et al. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro. J Cell Biochem. 2011;112(9):2412–23. Describes an in vitro model used to study gene expression of MLO-Y4 cells undergoing apoptosis, and the subsequent effect on osteoclastogenesis.PubMedCrossRef
22.
Zurück zum Zitat Zahm AM, Bucaro MA, Srinivas V, et al. Oxygen tension regulates preosteocyte maturation and mineralization. Bone. 2008;43(1):25–31.PubMedCrossRef Zahm AM, Bucaro MA, Srinivas V, et al. Oxygen tension regulates preosteocyte maturation and mineralization. Bone. 2008;43(1):25–31.PubMedCrossRef
23.
Zurück zum Zitat Genetos DC, Kephart CJ, Zhang Y, et al. Oscillating fluid flow activation of gap junction hemichannels induces ATP release from MLO-Y4 osteocytes. J Cell Physiol. 2007;212(1):207–14.PubMedCrossRef Genetos DC, Kephart CJ, Zhang Y, et al. Oscillating fluid flow activation of gap junction hemichannels induces ATP release from MLO-Y4 osteocytes. J Cell Physiol. 2007;212(1):207–14.PubMedCrossRef
24.
Zurück zum Zitat Kwon RY, Temiyasathit S, Tummala P, et al. Primary cilium-dependent mechanosensing is mediated by adenylyl cyclase 6 and cyclic AMP in bone cells. FASEB J. 2010;24(8):2859–68.PubMedCrossRef Kwon RY, Temiyasathit S, Tummala P, et al. Primary cilium-dependent mechanosensing is mediated by adenylyl cyclase 6 and cyclic AMP in bone cells. FASEB J. 2010;24(8):2859–68.PubMedCrossRef
25.
Zurück zum Zitat • Xia X, Kar R, Gluhak-Heinrich J, et al. Glucocorticoid-induced autophagy in osteocytes. J Bone Miner Res. 2010;25(11):2479–88. Demonstrates the effects of glucocorticoids on osteocytes in terms of autophagy and apoptosis. Proposes new mechanisms responsible for bone loss in patients receiving glucocorticoid therapy..PubMedCrossRef • Xia X, Kar R, Gluhak-Heinrich J, et al. Glucocorticoid-induced autophagy in osteocytes. J Bone Miner Res. 2010;25(11):2479–88. Demonstrates the effects of glucocorticoids on osteocytes in terms of autophagy and apoptosis. Proposes new mechanisms responsible for bone loss in patients receiving glucocorticoid therapy..PubMedCrossRef
26.
Zurück zum Zitat Plotkin LI, Aguirre JI, Kousteni S, et al. Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of extracellular signal-regulated kinase activation. J Biol Chem. 2005;280(8):7317–25.PubMedCrossRef Plotkin LI, Aguirre JI, Kousteni S, et al. Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of extracellular signal-regulated kinase activation. J Biol Chem. 2005;280(8):7317–25.PubMedCrossRef
27.
Zurück zum Zitat •• Batra N, Burra S, Siller-Jackson AJ, et al. Mechanical stress-activated integrin alpha5beta1 induces opening of connexin 43 hemichannels. Proc Natl Acad Sci USA. 2012;109(9):3359–64. Shows that mechanical perturbation or conformational activation of integrin α5β1 leads to the opening of the connexin 43 hemichannel, a potentially important pathway for cell-cell communication..PubMedCrossRef •• Batra N, Burra S, Siller-Jackson AJ, et al. Mechanical stress-activated integrin alpha5beta1 induces opening of connexin 43 hemichannels. Proc Natl Acad Sci USA. 2012;109(9):3359–64. Shows that mechanical perturbation or conformational activation of integrin α5β1 leads to the opening of the connexin 43 hemichannel, a potentially important pathway for cell-cell communication..PubMedCrossRef
28.
Zurück zum Zitat Heino TJ, Hentunen TA, Vaananen HK. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts. Exp Cell Res. 2004;294(2):458–68.PubMedCrossRef Heino TJ, Hentunen TA, Vaananen HK. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts. Exp Cell Res. 2004;294(2):458–68.PubMedCrossRef
29.
Zurück zum Zitat Tanaka-Kamioka K, Kamioka H, Ris H, et al. Osteocyte shape is dependent on actin filaments and osteocyte processes are unique actin-rich projections. J Bone Miner Res. 1998;13(10):1555–68.PubMedCrossRef Tanaka-Kamioka K, Kamioka H, Ris H, et al. Osteocyte shape is dependent on actin filaments and osteocyte processes are unique actin-rich projections. J Bone Miner Res. 1998;13(10):1555–68.PubMedCrossRef
30.
Zurück zum Zitat Cowin SC, Moss-Salentijn L, Moss ML. Candidates for the mechanosensory system in bone. J Biomech Eng. 1991;113(2):191–7.PubMedCrossRef Cowin SC, Moss-Salentijn L, Moss ML. Candidates for the mechanosensory system in bone. J Biomech Eng. 1991;113(2):191–7.PubMedCrossRef
31.
Zurück zum Zitat Weinbaum S, Cowin SC, Zeng Y. A model for the excitation of osteocytes by mechanical loading-induced bone fluid shear stresses. J Biomech. 1994;27(3):339–60.PubMedCrossRef Weinbaum S, Cowin SC, Zeng Y. A model for the excitation of osteocytes by mechanical loading-induced bone fluid shear stresses. J Biomech. 1994;27(3):339–60.PubMedCrossRef
32.
Zurück zum Zitat Skerry TM, Bitensky L, Chayen J, et al. Early strain-related changes in enzyme activity in osteocytes following bone loading in vivo. J Bone Miner Res. 1989;4(5):783–8.PubMedCrossRef Skerry TM, Bitensky L, Chayen J, et al. Early strain-related changes in enzyme activity in osteocytes following bone loading in vivo. J Bone Miner Res. 1989;4(5):783–8.PubMedCrossRef
33.
Zurück zum Zitat Dallas SL, Zaman G, Pead MJ, et al. Early strain-related changes in cultured embryonic chick tibiotarsi parallel those associated with adaptive modeling in vivo. J Bone Miner Res. 1993;8(3):251–9.PubMedCrossRef Dallas SL, Zaman G, Pead MJ, et al. Early strain-related changes in cultured embryonic chick tibiotarsi parallel those associated with adaptive modeling in vivo. J Bone Miner Res. 1993;8(3):251–9.PubMedCrossRef
34.
Zurück zum Zitat Dodds RA, Ali N, Pead MJ, et al. Early loading-related changes in the activity of glucose 6-phosphate dehydrogenase and alkaline phosphatase in osteocytes and periosteal osteoblasts in rat fibulae in vivo. J Bone Miner Res. 1993;8(3):261–7.PubMedCrossRef Dodds RA, Ali N, Pead MJ, et al. Early loading-related changes in the activity of glucose 6-phosphate dehydrogenase and alkaline phosphatase in osteocytes and periosteal osteoblasts in rat fibulae in vivo. J Bone Miner Res. 1993;8(3):261–7.PubMedCrossRef
35.
Zurück zum Zitat Gluhak-Heinrich J, Ye L, Bonewald LF, et al. Mechanical loading stimulates dentin matrix protein 1 (DMP1) expression in osteocytes in vivo. J Bone Miner Res. 2003;18(5):807–17.PubMedCrossRef Gluhak-Heinrich J, Ye L, Bonewald LF, et al. Mechanical loading stimulates dentin matrix protein 1 (DMP1) expression in osteocytes in vivo. J Bone Miner Res. 2003;18(5):807–17.PubMedCrossRef
36.
Zurück zum Zitat Verborgt O, Gibson GJ, Schaffler MB. Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J Bone Miner Res. 2000;15(1):60–7.PubMedCrossRef Verborgt O, Gibson GJ, Schaffler MB. Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J Bone Miner Res. 2000;15(1):60–7.PubMedCrossRef
37.
Zurück zum Zitat Yang W, Lu Y, Kalajzic I, et al. Dentin matrix protein 1 gene cis-regulation: use in osteocytes to characterize local responses to mechanical loading in vitro and in vivo. J Biol Chem. 2005;280(21):20680–90.PubMedCrossRef Yang W, Lu Y, Kalajzic I, et al. Dentin matrix protein 1 gene cis-regulation: use in osteocytes to characterize local responses to mechanical loading in vitro and in vivo. J Biol Chem. 2005;280(21):20680–90.PubMedCrossRef
38.
Zurück zum Zitat •• Cardoso L, Herman BC, Verborgt O, et al. Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J Bone Miner Res. 2009;24(4):597–605. Demonstrates that osteocyte apoptosis is an obligatory step toward osteoclastogenesis in response to microdamage in cortical bone..PubMedCrossRef •• Cardoso L, Herman BC, Verborgt O, et al. Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J Bone Miner Res. 2009;24(4):597–605. Demonstrates that osteocyte apoptosis is an obligatory step toward osteoclastogenesis in response to microdamage in cortical bone..PubMedCrossRef
39.
Zurück zum Zitat Zhang K, Barragan-Adjemian C, Ye L, et al. E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation. Mol Cell Biol. 2006;26(12):4539–52.PubMedCrossRef Zhang K, Barragan-Adjemian C, Ye L, et al. E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation. Mol Cell Biol. 2006;26(12):4539–52.PubMedCrossRef
40.
Zurück zum Zitat Ajubi NE, Klein-Nulend J, Nijweide PJ, et al. Pulsating fluid flow increases prostaglandin production by cultured chicken osteocytes–a cytoskeleton-dependent process. Biochem Biophys Res Commun. 1996;225(1):62–8.PubMedCrossRef Ajubi NE, Klein-Nulend J, Nijweide PJ, et al. Pulsating fluid flow increases prostaglandin production by cultured chicken osteocytes–a cytoskeleton-dependent process. Biochem Biophys Res Commun. 1996;225(1):62–8.PubMedCrossRef
41.
Zurück zum Zitat Wang L, Cowin SC, Weinbaum S, et al. Modeling tracer transport in an osteon under cyclic loading. Ann Biomed Eng. 2000;28(10):1200–9.PubMedCrossRef Wang L, Cowin SC, Weinbaum S, et al. Modeling tracer transport in an osteon under cyclic loading. Ann Biomed Eng. 2000;28(10):1200–9.PubMedCrossRef
42.
Zurück zum Zitat Wang L, Wang Y, Han Y, et al. In situ measurement of solute transport in the bone lacunar-canalicular system. Proc Natl Acad Sci USA. 2005;102(33):11911–6.PubMedCrossRef Wang L, Wang Y, Han Y, et al. In situ measurement of solute transport in the bone lacunar-canalicular system. Proc Natl Acad Sci USA. 2005;102(33):11911–6.PubMedCrossRef
43.
Zurück zum Zitat Squire JM, Chew M, Nneji G, et al. Quasi-periodic substructure in the microvessel endothelial glycocalyx: a possible explanation for molecular filtering? J Struct Biol. 2001;136(3):239–55.PubMedCrossRef Squire JM, Chew M, Nneji G, et al. Quasi-periodic substructure in the microvessel endothelial glycocalyx: a possible explanation for molecular filtering? J Struct Biol. 2001;136(3):239–55.PubMedCrossRef
44.
Zurück zum Zitat Burr DB, Martin RB, Schaffler MB, et al. Bone remodeling in response to in vivo fatigue microdamage. J Biomech. 1985;18(3):189–200.PubMedCrossRef Burr DB, Martin RB, Schaffler MB, et al. Bone remodeling in response to in vivo fatigue microdamage. J Biomech. 1985;18(3):189–200.PubMedCrossRef
45.
Zurück zum Zitat Burr DB, Forwood MR, Fyhrie DP, et al. Bone microdamage and skeletal fragility in osteoporotic and stress fractures. J Bone Miner Res. 1997;12(1):6–15.PubMedCrossRef Burr DB, Forwood MR, Fyhrie DP, et al. Bone microdamage and skeletal fragility in osteoporotic and stress fractures. J Bone Miner Res. 1997;12(1):6–15.PubMedCrossRef
46.
Zurück zum Zitat Bentolila V, Boyce TM, Fyhrie DP, et al. Intracortical remodeling in adult rat long bones after fatigue loading. Bone. 1998;23(3):275–81.PubMedCrossRef Bentolila V, Boyce TM, Fyhrie DP, et al. Intracortical remodeling in adult rat long bones after fatigue loading. Bone. 1998;23(3):275–81.PubMedCrossRef
47.
Zurück zum Zitat Verborgt O, Tatton NA, Majeska RJ, et al. Spatial distribution of Bax and Bcl-2 in osteocytes after bone fatigue: complementary roles in bone remodeling regulation? J Bone Miner Res. 2002;17(5):907–14.PubMedCrossRef Verborgt O, Tatton NA, Majeska RJ, et al. Spatial distribution of Bax and Bcl-2 in osteocytes after bone fatigue: complementary roles in bone remodeling regulation? J Bone Miner Res. 2002;17(5):907–14.PubMedCrossRef
48.
Zurück zum Zitat Cheng Y, Deshmukh M, D’Costa A, et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest. 1998;101(9):1992–9.PubMedCrossRef Cheng Y, Deshmukh M, D’Costa A, et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest. 1998;101(9):1992–9.PubMedCrossRef
49.
Zurück zum Zitat Nicholson DW. From bench to clinic with apoptosis-based therapeutic agents. Nature. 2000;407(6805):810–6.PubMedCrossRef Nicholson DW. From bench to clinic with apoptosis-based therapeutic agents. Nature. 2000;407(6805):810–6.PubMedCrossRef
50.
51.
Zurück zum Zitat •• Kennedy OD, Herman BC, Laudier DM, et al. Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations. Bone. 2012; doi: 10.1016/j.bone.2012.01.025. Demonstrates osteocyte expression of pro-osteoclastogenic factors by distinct cell populations in nearby sites of microdamage. •• Kennedy OD, Herman BC, Laudier DM, et al. Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations. Bone. 2012; doi: 10.​1016/​j.​bone.​2012.​01.​025. Demonstrates osteocyte expression of pro-osteoclastogenic factors by distinct cell populations in nearby sites of microdamage.
52.
Zurück zum Zitat Nakashima T, Kobayashi Y, Yamasaki S, et al. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun. 2000;275(3):768–75.PubMedCrossRef Nakashima T, Kobayashi Y, Yamasaki S, et al. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun. 2000;275(3):768–75.PubMedCrossRef
53.
Zurück zum Zitat •• Nakashima T, Hayashi M, Fukunaga T, et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011;17(10):1231–4. Shows that purified osteocytes express RANKL and have the capacity to support osteoclastogenesis in vitro. Also shows osteocytes are a major source of RANKL in bone remodeling in vivo.PubMedCrossRef •• Nakashima T, Hayashi M, Fukunaga T, et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011;17(10):1231–4. Shows that purified osteocytes express RANKL and have the capacity to support osteoclastogenesis in vitro. Also shows osteocytes are a major source of RANKL in bone remodeling in vivo.PubMedCrossRef
54.
Zurück zum Zitat •• Xiong J, Onal M, Jilka RL, et al. Matrix-embedded cells control osteoclast formation. Nat Med. 2011;17:1234–41. Uses a transgenic model with RANKL conditionally deleted to demonstrate that hypertrophic chondrocytes and osteocytes, both of which are embedded in matrix, are essential sources of the RANKL that controls mineralized cartilage resorption and bone remodeling, respectively.CrossRef •• Xiong J, Onal M, Jilka RL, et al. Matrix-embedded cells control osteoclast formation. Nat Med. 2011;17:1234–41. Uses a transgenic model with RANKL conditionally deleted to demonstrate that hypertrophic chondrocytes and osteocytes, both of which are embedded in matrix, are essential sources of the RANKL that controls mineralized cartilage resorption and bone remodeling, respectively.CrossRef
55.
Zurück zum Zitat Baron R, Tross R, Vignery A. Evidence of sequential remodeling in rat trabecular bone - morphology, dynamic histomorphometry, and changes during skeletal maturation. Anat Rec. 1984;208(1):137–45.PubMedCrossRef Baron R, Tross R, Vignery A. Evidence of sequential remodeling in rat trabecular bone - morphology, dynamic histomorphometry, and changes during skeletal maturation. Anat Rec. 1984;208(1):137–45.PubMedCrossRef
56.
Zurück zum Zitat Fisher M. The ischemic penumbra: identification, evolution and treatment concepts. Cerebrovasc Dis. 2004;17 Suppl 1:1–6.PubMedCrossRef Fisher M. The ischemic penumbra: identification, evolution and treatment concepts. Cerebrovasc Dis. 2004;17 Suppl 1:1–6.PubMedCrossRef
Metadaten
Titel
Osteocyte Signaling in Bone
verfasst von
Mitchell B. Schaffler
Oran D. Kennedy
Publikationsdatum
01.06.2012
Verlag
Current Science Inc.
Erschienen in
Current Osteoporosis Reports / Ausgabe 2/2012
Print ISSN: 1544-1873
Elektronische ISSN: 1544-2241
DOI
https://doi.org/10.1007/s11914-012-0105-4

Weitere Artikel der Ausgabe 2/2012

Current Osteoporosis Reports 2/2012 Zur Ausgabe

Skeletal Biology (D Burr, Section Editor)

Pathways for Bone Loss in Inflammatory Disease

Skeletal Regulations (D Gaddy, Section Editor)

Vitamin D and Bone

Skeletal Regulations (D Gaddy, Section Editor)

The NPY System and its Neural and Neuroendocrine Regulation of Bone

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.